Literature DB >> 19382319

Management of occult fractures in the skeletally immature patient: cost analysis of implementing a limited trauma magnetic resonance imaging protocol.

J Herman Kan1, Cristina Estrada, Uzma Hasan, Andrea Bracikowski, Yu Shyr, Bashar Shakhtour, Marta Hernanz-Schulman.   

Abstract

STUDY
OBJECTIVE: Fractures in children may not be visible in the result of initial radiography, and undertreatment and overtreatment of such fractures routinely occur. The purpose of this study was to evaluate the potential cost of implementing limited magnetic resonance imaging (MRI) at initial encounter, when radiographs are unrevealing.
METHODS: This was a retrospective review of 204 emergency department pediatric patients presenting between January 1, 2005 and February 28, 2006 with appendicular trauma, with initially negative radiographic result and follow-up. Emergency department treatment categorization of (1) no treatment, (2) ACE wrap, (3) brace, (4) splint, or (5) casting was evaluated. Final determination of presence or absence of fracture was based on follow-up. Patients with fractures were considered undertreated when they received categories 1 to 3 care; patients without fractures were considered overtreated when they received categories 4 and 5 care. The percentage of patients undertreated or overtreated and direct and total costs were determined and analyzed in conjunction with the cost of a limited MRI at initial encounter. Total costs include direct and indirect costs (lost wages for each day off work for the parent). Cost estimates assume patients determined to be without fractures at follow-up will not return for follow-up clinical care or obtain additional imaging after MRI at initial encounter.
RESULTS: Twenty-eight (13.7%) of the 204 patients had fractures at follow-up. Fifty one percent of patients without fractures were overtreated; 29% with fractures were undertreated. Mean direct cost for all patients and cost estimation with limited MRI protocol were $843.81 and $891.79, respectively (P = 0.365). However, mean total cost for all patients and cost estimation with limited MRI protocol was $1059.49 and $929.10, respectively (P = 0.02).
CONCLUSIONS: Based on clinical grounds and initially negative radiographic results, slightly more than half of patients without fractures can be overtreated, and nearly one third of patients with fractures can be undertreated. Instituting a protocol that includes limited trauma MRI lowers the total cost of care without increasing direct cost, and appropriate care may be instituted at the outset.

Entities:  

Mesh:

Year:  2009        PMID: 19382319     DOI: 10.1097/pec.0b013e31819e3635

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

1.  The role of MRI in musculoskeletal practice: a clinical perspective.

Authors:  Gail Dean Deyle
Journal:  J Man Manip Ther       Date:  2011-08

2.  Performance of a rapid two-sequence screening protocol for osteomyelitis of the foot.

Authors:  Adam D Singer; Monica Umpierrez; Aparna Kakarala; Marcos C Schechter; Michael Maceroli; Gulshan B Sharma; Ravi R Rajani
Journal:  Skeletal Radiol       Date:  2020-01-14       Impact factor: 2.199

3.  [Comparison of MRI and CT for assessment of childhood fractures: studies on a porcine model].

Authors:  J D Moritz; B Hoffmann; D Sehr; A Caliebe; G Groth; M Heller; H Bolte
Journal:  Unfallchirurg       Date:  2013-10       Impact factor: 1.000

Review 4.  Prevalence and clinical significance of occult fractures in children with radiograph-negative acute ankle injury. A meta-analysis.

Authors:  Abolfazl Najaf-Zadeh; Eric Nectoux; François Dubos; Laurent Happiette; Xavier Demondion; Magloire Gnansounou; Bernard Herbaux; Alain Martinot
Journal:  Acta Orthop       Date:  2014-05-30       Impact factor: 3.717

5.  Ultrasound diagnosis of either an occult or missed fracture of an extremity in pediatric-aged children.

Authors:  Kil-Ho Cho; Sung-Moon Lee; Young-Hwan Lee; Kyung-Jin Suh
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.